Echinacea alleviates ulcerative colitisEchinacea purpurea (L.) Moench extract suppresses inflammation by inhibition of C3a/C3aR signaling pathway in TNBS-induced ulcerative colitis rats.
Highly relevant study on ingredients
We investigated the protective effects of Echinacea purpurea extract on ulcerative colitis (UC), a chronic inflammatory condition affecting the gastrointestinal tract. To do this, we induced UC in rats using a compound called TNBS. Afterward, we treated them with Echinacea extract for ten days to assess its efficacy.
Our findings were promising! The Echinacea extract helped reduce weight loss and diarrhea in the rats with UC. We observed significant improvements in the integrity of the intestinal barrier, which is crucial for gut health.
Furthermore, we noted that the extract reduced levels of harmful inflammatory substances while boosting antioxidant activity. Impressively, Echinacea also inhibited several key proteins associated with inflammation, including C3aR and TLR4.
Overall, these results suggest that Echinacea purpurea could serve as a beneficial treatment for alleviating ulcerative colitis by targeting specific inflammatory pathways in the body.
Read More
Echinacea shows protective potentialThe protective effect of Echinacea spp. (Echinacea angustifolia and Echinacea purpurea) in a rat colitis model induced by acetic acid.
Relevant investigation of Echinacea
We explored the effects of Echinacea on ulcerative colitis, a chronic inflammatory condition affecting the colon. In our study, we induced colitis in rats using acetic acid and divided them into four groups: a control group, a group treated with Echinacea, a group with both Echinacea and colitis, and a colitis-only group.
Our results showed that the disease activity index (DAI) was notably higher in the colitis group when compared to the control and Echinacea groups. This indicates that Echinacea may have protective qualities, as those treated showed less severe symptoms. Key inflammatory markers such as tumor necrosis factor alpha (TNF-α) and interleukin-1 beta (IL-1β) were significantly elevated in the colitis group, supporting the potential role of Echinacea in reducing inflammation.
While we did not find a significant difference between the Echinacea and control groups, this study suggests that Echinacea may have promising effects in managing ulcerative colitis, and further research could strengthen our understanding of its therapeutic benefits.
Read More